Jorge Suarez
About Jorge Suarez
Jorge Suarez is the Manager of Biochemistry & Bioassay at BeiGene, with extensive experience in cell therapy development and a background in both business and biotechnology.
Current Position at BeiGene
Jorge Suarez currently holds the position of Manager, Biochemistry & Bioassay at BeiGene. In this role, he is responsible for overseeing biochemistry and bioassay operations, contributing significantly to the company's research and development efforts.
Previous Role at Bristol Myers Squibb
From 2020 to 2023, Jorge Suarez worked at Bristol Myers Squibb as Manager, Scientist-Cell Therapy Development. During his three-year tenure, Jorge specialized in cell therapy development, driving key initiatives in the field and enhancing the company's therapeutic capabilities.
Experience at Novartis
Jorge Suarez served as Associate Scientist in Bioanalytics Cell & Gene Therapy at Novartis from 2018 to 2020. Over these two years, he focused on bioanalytics, paving the way for advancements in cell and gene therapy, and supported various research projects.
Academic Background
Jorge Suarez has a robust academic background, holding an MBA from La Salle University. Additionally, he studied Biotechnology at Jefferson Health from 2009 to 2010 and completed an Integrated Science program with a concentration in Business and Technology Biotechnology from La Salle University from 2002 to 2007.
Diversity and Inclusion Leadership
In addition to his scientific roles, Jorge Suarez has also served as a Diversity & Inclusion Lead. He has been actively involved in promoting diverse and inclusive work environments throughout his career, contributing to the creation of a supportive and equitable workplace culture.
Extensive Industry Experience
Jorge Suarez has accumulated extensive experience in the biotechnology and pharmaceutical industries. He has worked in various capacities for over a decade, including roles at Penn Medicine, Regeneron Pharmaceuticals, and Merck. His work has primarily focused on quality control, virology, and clinical cell therapy, showcasing his diverse skill set.